Sherman Leung

Sherman is Head of Research Operations at Wesley Research Institute and is responsible for the strategic planning and operation of the Clinical Trials Centre, Biobank, Research Office and Research Programs.

Sherman holds a Bachelor of Science with first-class honours and a University Medal, and a PhD in translational research. He has held roles at Microba Life Sciences a Brisbane-based ASX-listed biotech, and was part of the leadership team at Nucleus Network – an early-stage clinical trials site for some of the world’s leading pharmaceutical and biotechnology companies. He is trained in Good Clinical Practice, is a certified PRINCE2 Practitioner, and has a track record in driving tangible change for research organisations, helping to improve their culture and performance.

He contributes his spare time to the greater good through being a Board Director of the Australian Clinical Trials Alliance (ACTA), Co-Chair to the Clinical and Consumer Advisory Group of the $75m Australian Teletrials Program, Co-Chair to the Clinical Trials Advocacy Working Group of the Queensland Clinical Trials Consortium (QCTC), former member of the Metro North Human Research Ethics Committee (HREC), and Editorial Board for ‘Trials’ – a journal promoting all aspects of trials including methods, processes and non-significant outcomes for transparency in the field.